Laman UtamaTHYROCARE • NSE
add
Thyrocare Technologies Ltd
Tutup sebelumnya
₹636.40
Julat hari
₹631.00 - ₹642.70
Julat tahun
₹506.80 - ₹722.65
Permodalan pasaran
33.93B INR
Bilangan Purata
75.79K
Nisbah P/E
47.40
Hasil dividen
-
Pertukaran utama
NSE
Berita pasaran
NVDA
2.48%
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(INR) | Mac 2024info | Perubahan T/T |
---|---|---|
Hasil | 1.54B | 13.52% |
Perbelanjaan pengendalian | 603.60J | 67.39% |
Pendapatan bersih | 177.80J | 42.58% |
Margin untung bersih | 11.53 | 25.60% |
Pendapatan bagi setiap syer | 3.54 | 50.00% |
EBITDA | 325.02J | 43.91% |
Kadar cukai berkesan | 24.98% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
(INR) | Mac 2024info | Perubahan T/T |
---|---|---|
Pelaburan tunai dan jangka pendek | 1.77B | 26.11% |
Jumlah aset | 6.44B | 1.76% |
Jumlah liabiliti | 1.16B | 19.23% |
Jumlah ekuiti | 5.28B | — |
Syer tertunggak | 50.23J | — |
Harga kepada buku | 6.07 | — |
Pulangan pada aset | — | — |
Pulangan pada modal | 9.39% | — |
Aliran Tunai
Perubahan bersih dalam tunai
(INR) | Mac 2024info | Perubahan T/T |
---|---|---|
Pendapatan bersih | 177.80J | 42.58% |
Tunai daripada operasi | — | — |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | — | — |
Perubahan bersih dalam tunai | — | — |
Aliran tunai bebas | — | — |
Perihal
Thyrocare Technologies Limited is an Indian multinational chain of diagnostic and preventive care laboratories, headquartered in Navi Mumbai. As of 2021, the company has a total of 1,122 outlets and collection centers across India and parts of Nepal, Bangladesh and the Middle East.
On 26 June 2021, Indian e-pharmacy and online healthcare aggregator PharmEasy's parent API Holdings acquired a 66.1% controlling stake in Thyrocare, making Thyrocare the first Indian listed company to be acquired by a startup. Wikipedia
Diasaskan
1996
Ibu pejabat
Tapak web
Pekerja
1,645